Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 59

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 59
---
 $3,083,154  
    $(1,288,382) 
    $3,101,859  
    $(1,288,382)

    Basic weighted average shares outstanding 
     10,071,183  
     1,312,544  
     10,071,183  
     1,312,544 
  
    Dilutive effect of preferred stock  

     61,100  
     - 
  
    Dilutive effect of restricted stock units 

     75,659  
     - 
  
    Dilutive weighted average shares outstanding 

     10,207,942  
     1,312,544 

    Earnings (loss) per share 
    $0.31  
    $(0.98) 
    $0.30  
    $(0.98)

None of the potential dilutive securities had
a dilutive impact during the three and six months ended June 30, 2024 due to the Company’s net loss.

The number of anti-dilutive shares for both the
three and six months ended June 30, 2025, consisting of common shares underlying (i) preferred stock, (ii) common stock options, (iii)
restricted stock units and (iv) stock purchase warrants, which have been excluded from the computation of diluted income per share, was
1.4 million shares.

The number of anti-dilutive shares for both the
three and six months ended June 30, 2024, consisting of common shares underlying (i) preferred stock, (ii) common stock options, (iii)
restricted stock units and (iv) stock purchase warrants, which have been excluded from the computation of diluted income per share, was
2.5 million shares.

    13

Recently issued accounting standards

In July 2025, the FASB issued ASU No. 2025-05:
Financial Instruments-Credit Losses which amends topic 326. Specifically, the ASU provides a practical expedient whereby an entity can
assume that current conditions as of the balance sheet date will not change for the remaining life of the asset (e.g., the accounts receivable).
This guidance is effective for the Company’s fiscal year ending December 31, 2026 and can be adopted early. The Company is in the
process of evaluating the effects of this guidance on its condensed consolidated financial statements.

In September 2025,